Teva Pharmaceutical Industries Ltd On Tuesday Made Its Generic Version Of Mylans Epipen For Young Children Available In Most Retail Pharmacies At $300 For A 2-Pack.U.S-Listed Shares Of The Israel-Based Company Rose 4.9% To $7 In Afternoon Trading.Teva, The Worlds Largest Generic Drugmaker, Is Already Selling The Product For Adults, After Getting U.S. Approval For Its Copy Of Epipen Last August, Following Several Years Of Delay.
